BUSINESS● LOWSep 1 · Sep 1, 2026, 3:15 AM
Small Cap Watch : XSO extends decline as Percheron funds AML trial and Nova advances US antimony plans
proactiveinvestors.com.au · Australia · north america
Small-cap stock XSO is continuing its decline as Percheron funds an AML trial and Nova progresses with its US antimony initiatives. This reflects specific company and market movements in the small-cap sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Australia
WORLD3h agoIn Australia, Sydney’s second airport blows some passengers off courseSouth China Morning PostPOLITICS3h agoAustralian minister says he is being followed after bullet etched with ‘RAT’ left on carThe Independent WorldBUSINESS5h agoJane McMillan elected to Cattle Australia board as director | The North West Starnorthweststar.com.au · AustraliaPOLITICS6h agoAustralian parliament pays tribute to Helen Haines as PM Albanese condemns increasing ‘rage and aggression’The Independent World
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS25m agoWuXi AppTec Non-GAAP EPS of RMB 6.21, revenue of RMB 45.54B; rasies full-year guidanceSeeking Alpha TechBUSINESS25m agoEasterly Government FFO of $0.78 in-line, revenue of $93.61M beats by $0.93MSeeking Alpha Tech